Innovation of Shanghai Haoyuan Chemexpress Co., Ltd.

ChemExpress leads the field for ADC drug development providing one-stop CRO & CDMO services for both small molecules and ADC conjugation.

ChemExpress have a substantial inventory of over 80 payloads and 400 linkers, in addition to extensive expertise in linker compound synthesis, with over 1,000 successful syntheses.

To date, ChemExpress have empowered over 800 clients to develop their ADC projects. We have collaborated with RemeGen to assist in the development and launching of RC48—the first ADC drug developed and approved in China.

As of August 2024, ChemExpress have 12 ADC related products with DMF. Our clients can directly cite the specific DMF code, thereby expediting the drug review process.

ChemExpress ADC CDMO Services

ChemExpress DMF-Filed ADC Products

MMAE Series

MMAE & Intermediates

Exatecan Series

Exatecan & Intermediates

Eribulin Series

Eribulin Intermediates

Trabectedin Series

Trabectedin Intermediates

Click to learn more about our ADC products

Payloads (80+)>>:

MMAE; Exatecan; Eribulin; PNU-159682; PBD;

Amanitin; Tubulysin; Duocarmycin; STING Agonist, etc.

Linkers (400+)>>:

Ac-{Gly(N-me)}-Sar-Sar-Sar-Sar-Sar-Sar-Sar-Sar-Sar;

Mc-Val-Ala-PAB-PNP;

DBCO-acid;

MAC qlucuronide linker-2;

Mc-Val-Cit-PABC-PNP;

Lys(MMT)-PAB-oxydiacetamide-PEG8-N3;

Fmoc-Val-Cit-PAB-PNP, etc.

Helpful Resources

ChemExpress ADC Small Molecule Product Handbook>>

ChemExpress ADC CDMO Services Brochure>>

Upcoming Events

CPHI Korea 2024